AU2361495A - A novel vzv gene, mutant vzv and immunogenic compositions - Google Patents
A novel vzv gene, mutant vzv and immunogenic compositionsInfo
- Publication number
- AU2361495A AU2361495A AU23614/95A AU2361495A AU2361495A AU 2361495 A AU2361495 A AU 2361495A AU 23614/95 A AU23614/95 A AU 23614/95A AU 2361495 A AU2361495 A AU 2361495A AU 2361495 A AU2361495 A AU 2361495A
- Authority
- AU
- Australia
- Prior art keywords
- vzv
- novel
- mutant
- immunogenic compositions
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000002163 immunogen Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/25—Varicella-zoster virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23540694A | 1994-04-28 | 1994-04-28 | |
US235406 | 1994-04-28 | ||
PCT/US1995/004971 WO1995029991A1 (en) | 1994-04-28 | 1995-04-20 | A novel vzv gene, mutant vzv and immunogenic compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2361495A true AU2361495A (en) | 1995-11-29 |
Family
ID=22885358
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU23614/95A Abandoned AU2361495A (en) | 1994-04-28 | 1995-04-20 | A novel vzv gene, mutant vzv and immunogenic compositions |
Country Status (3)
Country | Link |
---|---|
US (2) | US6087170A (en) |
AU (1) | AU2361495A (en) |
WO (1) | WO1995029991A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6528066B1 (en) * | 1999-09-14 | 2003-03-04 | University Of Iowa Research Foundation | Variant varicella-zoster viruses and methods of use |
US7517688B2 (en) * | 2000-02-25 | 2009-04-14 | Stratagene California | Method for ligating nucleic acids and molecular cloning |
CA2401632A1 (en) * | 2000-02-25 | 2001-08-30 | Stratagene | Method for ligating nucleic acids and molecular cloning |
US20090226889A1 (en) * | 2008-01-14 | 2009-09-10 | Chen Fan | Methods and compositions for detecting cns viruses |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4769239A (en) * | 1984-08-21 | 1988-09-06 | Merck & Co., Inc. | Vaccine against varicella-zoster virus |
US4686101A (en) * | 1985-08-02 | 1987-08-11 | Merck & Co., Inc. | Vaccine against varicella-zoster virus |
US4952674A (en) * | 1986-05-02 | 1990-08-28 | Merck & Co., Inc. | Vaccine against varicella-zoster virus |
US5310668A (en) * | 1986-06-20 | 1994-05-10 | Merck & Co., Inc. | Varicella-zoster virus as a live recombinant vaccine |
WO1993024616A1 (en) * | 1992-06-04 | 1993-12-09 | Merck & Co., Inc. | Process for attenuated varicella zoster virus vaccine production |
-
1995
- 1995-04-20 AU AU23614/95A patent/AU2361495A/en not_active Abandoned
- 1995-04-20 WO PCT/US1995/004971 patent/WO1995029991A1/en active Application Filing
-
1997
- 1997-05-16 US US08/857,534 patent/US6087170A/en not_active Expired - Lifetime
-
2000
- 2000-07-10 US US09/613,298 patent/US6713296B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US6713296B1 (en) | 2004-03-30 |
US6087170A (en) | 2000-07-11 |
WO1995029991A1 (en) | 1995-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0710798A3 (en) | Oxy-fuel burner | |
AU2162597A (en) | A novel composition, its preparation and use | |
AU2697797A (en) | Diamond-like nanocomposite compositions | |
AU5983994A (en) | Universal implant abutment | |
AU2870697A (en) | Oxygen-fuel burner | |
AU7373094A (en) | Ventilator prosthesis | |
AU1797799A (en) | Impedance-heated furnace | |
AU4397396A (en) | Mutant luciferases | |
AU1119399A (en) | Microorganism genomics, compositions and methods related thereto | |
AU2215995A (en) | Freeze-dried compositions comprising rna | |
AU5873498A (en) | Mutant (msbb) or (htrb) genes | |
AU8053898A (en) | Immunogenic compositions | |
AU1046995A (en) | Twin blower airhouse | |
AU2668195A (en) | Continuous furnace | |
AU3473995A (en) | Novel acylphosphine oxides | |
AU3811795A (en) | Mutant mono-oxygenase cytochrome p-450cam | |
AU2361495A (en) | A novel vzv gene, mutant vzv and immunogenic compositions | |
AU4844796A (en) | A prolonged release composition, use and production thereof | |
AU2792195A (en) | Chondramides, production methods, compositions comprising chondramides and cultures for chondramide production | |
AU4314696A (en) | Novel aromatic yeast strains | |
AU2635295A (en) | A novel neuronal-neonatal gene: neuronatin | |
AU1110699A (en) | Estra-1,3,5(10)-triene-7alpha-thioethers | |
AU4334797A (en) | Yeast composition | |
AU3452997A (en) | Vaccine compositions | |
AU2137095A (en) | Heterocyclyl-1,3,4-thiadiazolyloxyacetamides |